Where to get wurn technique

President of www. Other research demonstrates that stress can cause changes in ovulation, changes in cycle length and tubal spasms. The combination of mental and physical reactions can lead to a downward spiral and an overall feeling of a loss of control.

Techniques that help women work with and release stress can enhance feelings of control. Massage-based techniques and movement therapies help to break the vicious cycle by encouraging relaxation. More specifically, they can help relax tense muscles and tight connective tissues that may have been constricting blood vessels, and thus enable blood to flow more freely. Soothing massage helps reduce emotional tension, induce relaxation, calm stress-related conditions and may help women with hormone-related difficulties.

About 12 years ago, massage therapist Larry Wurn and his wife Belinda, a physical therapist, came across an alternative treatment for female infertility related to mechanical problems. While treating an infertile woman for low-back and pelvic pain, the therapists discovered their client became pregnant, after seven years of infertility. What made it especially interesting was the client had been diagnosed with two blocked fallopian tubes and had been sexually active the entire time.

Intrigued, the massage therapists tried the same technique on eight other infertile women. Half of them became pregnant following the massage therapy.

They were encouraged by an early success rate of 50 percent treating female infertility with the process, according to Belinda Wurn. That rate has now climbed to more than 70 percent. She had suffered two miscarriages, an ectopic tubal pregnancy and a failed attempt to open her tubes surgically, when she came for the therapy. She became pregnant after one week of therapy here and is due to deliver next week.

The therapy addresses adhesions, spasm and mechanical factors that cause almost half of all female infertility. Patients often have a history of miscarriage, tubal blockage, difficulty with implantation, sperm or egg transport.

In one study of 22 women who had completed the program, 16 are now pregnant or delivered following treatment. According to Marvin Heuer, M.

Without surgery or drugs, there is a significant decrease in complications. The main side effect appears to be decreased pain. Gynecological researcher Richard King, M. Clinical studies are ongoing. The therapy may be used as the sole treatment, or in combination with other techniques, such as acupuncture, or with assisted reproduction techniques like intrauterine inseminations and IVF. Therapy alone was the primary treatment in 13 of the infertility reversals, according to Wurn. In three other successes, women had the therapy prior to IVF, to increase uterine receptivity.

In six separate cases, patients reported the therapy cleared at least one fallopian tube that had been blocked prior to therapy. The Wurn treatment seems to help women who have adhesions in their reproductive tract. Patients can feel the pain and tell their physicians about it, but the doctors often cannot see them.

This makes the problem harder to diagnose. We studied with the leaders and developers of myofascial release, visceral manipulation, craniosacral therapy, several types of osteopathic manipulation, and a dozen other soft-tissue therapies—techniques that focus on muscles, organs, blood vessels, nerves, and connective tissue.

After every course, we examined each technique, keeping and modifying the ones that seemed to decrease my adhesions and relieve my pain. Our technique breaks down adhesions crosslink by crosslink. When that happens, tissues become as mobile as they were before the adhesions formed. A typical session involves one-on-one care with your therapist in a private treatment room.

About 25 percent have no pain, but have decreased function such as infertility, blocked fallopian tubes, or poor digestion. About 25 percent of our patients are physicians, nurses, pharmacists, or other healthcare professionals. We tend to treat the most complex cases, including longstanding pelvic pain, women who experience pain during intercourse, post-surgical adhesions from hysterectomy or c-section, partial bowel obstructions, blocked fallopian tubes, and women experiencing fertility issues who have been unsuccessful trying the traditional medical model.

This includes genital scarring from early childhood for women who lived in cultures practicing female circumcision. Our work addresses their physical scars, and it seems to help many of them understand that touch can be gentle, respectful, and caring—much different from their prior traumatic experiences. Because each of our patients has lived in her body all her life, we recognize that each has an intimate knowledge that may be vital to her improvement.

For that reason, we find it essential to inquire and to listen deeply to our patients. Some women started reporting toe-curling or first-time-ever orgasms; others were having dramatic increases of desire or lubrication, despite advanced age. These are results we never expected, and that Western medicine has never seen before.

We were surprised and pleased that a natural therapy that addressed adhesions could elicit such profound results. The Wurns estimate that their therapy has eliminated pain or improved function in thousands of complex cases over the last two decades. Unlike drugs and surgery, there are few risks or side effects to hands-on therapies, so give them a try.

You have nothing to lose but your pain! The book gets its title from the three areas where the Wurns have seen the greatest success. Neither Larry nor I could accept the fact that I would have debilitating pelvic pain for the rest of my life. Using templates by Cochrane Public Health Group and Newcastle-Ottawa Scale, each author extracted data, assessed bias, and computed minimal clinically important difference.

Any conflicts were resolved through discussion. In total, 7 of 7, articles from to were included; 3 RCTs and 4 observational studies were organized into 4 categories of CAM: naturopathy, Chinese medicine, homeopathy, and others. Limited evidence supported the use of Pimpinella anisum and crenotherapy for CRS. Data available on Chinese medicine, homeopathy, and liposomal therapy in CRS were inconclusive due to inherent flaws in the studies. No significant adverse events AEs have been found.

These researchers stated that given its widespread use, more rigorous data from high-quality research are needed before it can be routinely recommended. A total of 8 studies were identified; 2 studies were included in the meta-analysis.

The complementary interventions studied were acupuncture, exercise, electrotherapy, and yoga. All were inconclusive in affirming benefit, but demonstrated a positive trend in the treatment of symptoms of endometriosis.

The authors concluded that numerous complementary treatments have been used to alleviate the symptoms of endometriosis, but only acupuncture has demonstrated a significant improvement in outcomes.

Nevertheless, other approaches demonstrated positive trends toward improving symptoms; this should encourage investigators to design controlled studies to support their applicability. A total of 6 electronic databases "generalized anxiety disorder " and "randomized trial" and reference lists of identified publications were searched to March Of the 6, screened records, 32 were included 18 on biologically-based therapies, exclusively herbal preparations; 8 on manipulative and body-based therapies; and 3 on alternative medical systems and 3 on mind-body therapies.

Cochrane Collaboration methodology was used for quality assessment and data extraction. Network meta-regression reduced heterogeneity and suggested a modest Kava effect [end-of-treatment Hamilton Anxiety scale score difference adjusted for baseline scores and trial duration: - 3.

Safety reporting was poor. Apparent efficacy of certain herbal preparations and body-based therapies requires further confirmation. Findings show that free radical activity and oxidative stress indices are higher in the blood and duodenal juice of patients with pancreatitis.

Based on these findings, the idea of using antioxidant regimens in the management of both AP and CP as a supplement and complementary in combination with its traditional therapy is reasonable. In practice, however, the overall effectiveness of antioxidants is not known, and the best mixture of agents and dosages is not clear.

Currently, a trial of a mixture of antioxidants containing vitamin C, vitamin E, selenium, and methionine is reasonable as one component of overall medical management. In summation, there is no definite consensus on the dosage, length of therapy, and ultimately, the benefits of antioxidant therapy in the management of AP or CP. These IV infusions mainly consist of phosphatidylcholine, with syringe pushes of leucovorin, glutathione and a shot of vitamin B It can be administered as much as one can handle, and is slowly reduced as the cells heal.

However, there is a lack of evidence regarding the clinical value of the PK Protocol. Spascupreel Injection Solution is a homeopathic drug indicated for the relief of spasms of the smooth musculature of the gastro-intestinal GI and the urogenital tract as well as general muscle spasms. Each 1. Muller-Krampe and colleagues noted that GI spasms and cramps are common in children as well as in adults. Alternative medical practices such as chiropractic and homeopathy are becoming increasingly popular in Europe and the United States.

The effectiveness and tolerability of the homeopathic preparation Spascupreel SP was compared with that of hyoscine butylbromide treatment in children less than 12 years of age. These researchers carried out an observational cohort study of children less than 12 years over a 1-week treatment period.

Evaluation was performed by the practitioner based on information given by the patient or care-giver. Both treatments were very well-tolerated.

The authors concluded that for patients opting for a homeopathic therapy, SP appeared to be an effective and well-tolerated alternative to conventional therapies in children suffering from GI spasms. This was an observation, single-center study; its findings need to be validated by well-designed studies.

Theodorou and associates noted that irritable bowel syndrome IBS is a common disorder worldwide. Due to the multi-factorial pathophysiology and the heterogeneity of IBS patients, appropriate treatment of IBS is still a challenge. Spascupreel, as a multi-component medication, has the potential to modulate multiple pathophysiological pathways simultaneously.

These investigators examined the effects of oral SP treatment on stress-induced changes of peripheral and central functions in a rat model mimicking human IBS. These included the hypothalamic-pituitary-adrenal HPA axis response through plasma adrenocorticotropic hormone ACTH and corticosterone measurements, visceral pain in response to colorectal distension, gut permeability, colonic mast cell number, and sensitization as well as gut transit time. At the gut level, a reduction in colonic hypersensitivity to colorectal distension, a normalization of gut transit time acceleration, a reduced mast cell sensitization, and a trend toward reduced gut hyperpermeability were observed.

The authors concluded that these findings suggested that stress-induced IBS signs can be reduced using SP in rats. The observed effects and the good tolerability of the drug made SP an innovative candidate in the management of IBS. Zalta determined the effectiveness of massage therapy in the rehabilitation of post-anterior cruciate ligament ACL reconstruction patella-femoral pain syndrome PFPS. The primary complications following surgical repair of the ACL -- classified as PFPS -- are hamstring flexion contracture and quadriceps weakness, leading to patella-femoral dysfunction and retro-patellar pain.

Treatment included lymphatic drainage, myofascial release, neuromuscular techniques including trigger-point release, muscle energy techniques and cross-fiber friction. Orthopedic physical assessment tests were used to chart changes in patella-femoral function and changes in ROM in the knee during the course of the massage interventions. Subjective reporting on pain level and function were also documented. A decrease in pain level, hamstring flexion contracture and lateral tracking of the patella were documented.

The author concluded that massage therapy was determined to be an effective complementary therapy in the treatment of PFPS. This was a single-case study; and its findings were confounded by the use of multiple modalities.

Group I had TM that uses effleurage, petrissage, tapping and friction. Group II had DTM that uses oblique pressure, a combination of lengthening and cross-fiber strokes, anchor and stretch, freeing muscle from entrapment. Both groups did not have other treatment. There were no statistically significant differences between groups according to age and body mass index BMI.

Moreover, they stated that further research is needed to verify these findings. Streit stated that neurogenic thoracic outlet syndrome NTOS is a neuromuscular condition affecting brachial plexus functionality. NTOS is characterized by paresthesia, pain, muscle fatigue, and restricted mobility in the upper extremity UE.

The author reported on the case of a year old woman with NTOS who received 8 treatments over 35 days. Treatment included myofascial release, trigger-point therapy, cross fiber friction XFF , muscle stripping, and gentle passive stretching.

A resisted muscle test evaluated UE strength. The client rated symptoms daily via a VAS. The author concluded that these findings suggested that MT may be useful as part of a broad approach to managing NTOS symptoms and improving mobility.

Urbanelli et al noted that exosomes are small extracellular vesicles EVs; 30 to nm of endosomal origin, which are gaining the attention of the scientific community. Originally considered only a waste disposal system, they are now emerging as another class of signal mediators.

Exosomes are secreted by any cell type and retrieved in every body fluid, such as blood, urine, saliva and amniotic liquid. Remarkably, their biochemical content includes not only lipids and proteins, but also nucleic acids, mainly miRNA and mRNA, with a few reports also indicating the presence of genomic and mitochondrial DNA.

Their properties have stimulated extensive research to exploit them as a source of biomarkers for the diagnosis and the follow-up of several pathologies. Furthermore, exosomes are relatively robust and stable, so they appear attractive as gene and drug delivery vehicles. They have also revealed immunomodulatory and regenerative properties, which are encouraging their application for therapeutic purposes. Several issues remain to be addressed: exosome isolation is still time-consuming and unsatisfactorily reproducible, making it difficult to compare results among laboratories, improve the knowledge of their physiological function and correlate their features with pathological outcomes.

Nevertheless, the number of patents trying to address these problems is growing exponentially and many novelties will reach the scientific community in the next few years.

Tao et al noted that osteoarthritis OA is the most common joint disease throughout the world. SMSCs were transfected with or without miRp. Proliferation, migration and ECM secretion were measured in-vitro and compared between groups. The mechanism involving alternative Wnt signaling and activation of Yes-associated protein YAP was investigated using lentivirus, oligonucleotides or chemical drugs.

The preventative effect of exosomes in-vivo was measured using Safranin-O and Fast green staining and immunohistochemical staining. Wnt5a and Wnt5b carried by exosomes activated YAP via the alternative Wnt signaling pathway and enhanced proliferation and migration of chondrocytes with the side-effect of significantly decreasing ECM secretion. Highly-expressed miRp blocked this side-effect via RalA.

These investigators first found a potential source of exosomes and studied their merits and shortcomings. Based on their understanding of the molecular mechanism, these researchers overcame the shortcomings by modifying the exosomes. Such exosomes derived from modified cells hold potential as future therapeutic strategies.

Campanella et al stated that EVs are lipid membrane vesicles released by all human cells and are widely recognized to be involved in many cellular processes, both in physiological and pathological conditions. They are mediators of cell-cell communication, at both paracrine and systemic levels; thus, they are active players in cell differentiation, tissue homeostasis, and organ re-modeling.

Due to their ability to serve as a cargo for proteins, lipids, and nucleic acids, which often reflects the cellular source, they should be considered the future of the natural nano-delivery of bio-compounds.

To-date, natural nano-vesicles, such as exosomes, have been shown to represent a source of disease biomarkers and have high potential benefits in regenerative medicine. Indeed, they deliver both chemical and bio-molecules in a way that within exosomes drugs are more effective that in their exosome-free form. Therefore, to-date, it is known that exosomes are shuttle disease biomarkers and probably the most effective way to deliver therapeutic molecules within target cells. However, it is unclear exactly which exosomes may be used in therapy in avoiding side effects as well.

In regenerative medicine, it will be ideal to use autologous exosomes, but it appeared not ideal to use plasma-derived exosomes, as they may contain potentially dangerous molecules. The authors presented a contradictory relatively unmet issue that is the lack of a general agreement on the choice for the source of EVs for therapeutic use.

Fang and Vangsness stated that EVs released from cells that are a part of many biological and pathological processes, especially in intercellular communication. These vesicles are involved cell signaling, influence tissue and immune response, and serve as biomarkers for diseases. Most interesting are the exosomes that are released from MSCs for inflammation in joint diseases.

Preliminary studies have demonstrated the advantages of using EVs rather than MSCs for cell free therapy. Research on exosomes have shown promising results as biomarkers for tracking the pathogenesis and prognosis of inflammatory arthritis. Therapeutically, animal studies have demonstrated immunosuppression, reversing inflammation, increasing chondrocyte proliferation, and drug delivery properties.

The author concluded that the field of exosomes continues to develop and more basic science and clinical studies with safety and efficacy studies are needed. Saghatelyan and colleagues stated that the clinical efficacy of curcumin has not yet been established for the treatment of cancer, despite a large body of evidence from numerous pre-clinical studies suggesting the therapeutic potential of curcumin, especially when combined with paclitaxel.

The main obstacle in using curcumin for adjunctive cancer therapy is its low bioavailability via oral administration.

In a randomized, double-blind, placebo-controlled, parallel-group comparative clinical trial, these researchers examined the safety and efficacy of intravenous curcumin infusion in combination with paclitaxel in patients with metastatic and advanced breast cancer.

A superior effect of curcumin versus placebo was observed in both patients who had completed the treatment and all patients included in the ITT analysis, 3 months after termination of the treatment. However, the patients' self-assessed overall physical performance was significantly higher with curcumin than the placebo during the treatment and at the end of the follow-up, suggesting better tolerance in the curcumin group.

The authors concluded that treatment with curcumin in combination with paclitaxel was superior to the paclitaxel-placebo combination with respect to ORR and physical performance after 12 weeks of treatment. Intravenously administered curcumin caused no major safety issues and no reduction in QOL, and it may be beneficial in reducing fatigue. This was the first clinical trial that examined the safety and efficacy of administering curcumin intravenously in combination with chemotherapy in the treatment of cancer patients.

Troselj and co-workers stated that most data published on curcumin and curcumin-based formulations are very promising. In cancer research, the majority of data has been obtained in-vitro; less frequently, researchers used experimental animals. The results of several clinical studies were conclusive, and these studies have established a good foundation for further research focusing on implementing curcumin in clinical oncology; however, the issues regarding timely data reporting and lack of disclosure of the exact curcumin formulations used in these studies should not be neglected.

These researchers provided a review of the current status of publicly available data on curcumin clinical trials and a detailed presentation of results obtained so far with some curcumin formulations. Phenomena related to the observed effects of curcumin shown in clinical trials were presented, and its modifying effect on gut microbiota and metabolic re-programming was discussed.

The authors concluded that based on available data, there is a strong indication that curcumin and its metabolites present molecules that do not necessarily need to be abundant in order to act locally and benefit systemically; and future clinical trials should be designed in a way that will take that fact into consideration.

Fabianowska-Majewska and associates noted that one of the most systematically studied bioactive nutraceuticals for its benefits in the management of various diseases is the turmeric-derived compounds: curcumin. Curcumin is well known for its potential role in inhibiting cancer by targeting epigenetic machinery, with DNA methylation at the forefront. The dynamic DNA methylation processes serve as an adaptive mechanism to a wide variety of environmental factors, including diet.

Every healthy tissue has a precise DNA methylation pattern that changes during cancer development, forming a cancer-specific design. Hypermethylation of tumor suppressor genes, global DNA demethylation, and promoter hypomethylation of oncogenes and pro-metastatic genes are hallmarks of nearly all types of cancer, including breast cancer. Curcumin has been shown to modulate epigenetic events that are dysregulated in cancer cells and possess the potential to prevent cancer or enhance the effects of conventional anti-cancer therapy.

Although mechanisms underlying curcumin-mediated changes in the epigenome remain to be fully elucidated, the mode of action targeting both hyper-methylated and hypo-methylated genes in cancer is promising for cancer chemoprevention.

The authors provided a comprehensive discussion of potential epigenetic mechanisms of curcumin in reversing altered patterns of DNA methylation in breast cancer that is the most commonly diagnosed cancer and the leading cause of cancer death among women worldwide. These researchers stated that curcumin showed promising chemo-preventive effects in the laboratory experiments; however, its clinical application is still limited because of low water solubility and low metabolic stability.

Nevertheless, the numerous studies undergoing in various laboratories and clinics intensively working on evolving novel phytochemical-based therapeutic options for breast cancer implies that phytochemicals such as curcumin are the leading molecules for future anti-cancer drug development targeting breast cancer-related signaling pathways. Moreover, the effective doses of curcumin have not been shown to exert any toxicities or side effects making this bioactive compound ideal preventative and anti-cancer agent.

Therefore, the principal challenges in the examination of curcumin as an epigenetic anti-cancer agent are new strategies of increasing its bioavailability, evaluating the efficacy of the metabolites and determining the role of this phytochemical alone or in combination with other turmeric-derived compounds and existing drugs in improving anti-cancer efficacy.

These important issues should be addressed in future nutria-epigenomic studies. These investigators stated that while there is much more to be done, the available data so far indicate that curcumin can be a potential target of drug development against cancer. Each patient's subjective impression of change in pain intensity and duration of pain relief after each treatment was recorded, along with an point numeric rating scale NRS for pain intensity, immediately before and after each infusion.

Short-term lidocaine analgesia was examined by the reduction in NRS pain score according to the patients reported pre- immediately before treatment and post-treatment immediately after treatment values. Long-term analgesia was examined at follow-up visits by the patient's subjective impression of change in pain intensity and duration of pain relief.

Although there was a trend of greater response to magnesium sulfate as a beneficial adjunct to the lidocaine infusion, these researchers were unable to find a statistically significant difference for any of the variables studied. The authors concluded that the findings of this study demonstrated that escalating doses of IV lidocaine to 7.

Moreover, these researchers stated that larger, prospective clinical studies are needed to confirm these findings. Pharmaco-puncture is a relatively new form of acupuncture combining acupuncture with herbal medicine, and it has been used under various conditions in Korea. Currently, there is inadequate evidence supporting the use of pharmaco-puncture. Cheon et al stated pharmaco-puncture, injection to acupoints with pharmacological medication or herbal medicine, is a new acupuncture therapy widely available in Korea and China for cancer-related symptoms; however, the evidence is still unclear.

These researchers examined the effectiveness of pharmaco-puncture on cancer-related symptoms. A total of 11 databases were searched for RCTs of pharmaco-puncture in cancer patients.

The Cochrane risk of bias ROB assessment tool was used for quality assessment. A total of 22 studies involving 2, patients were included; 5 trials of chemotherapy-induced nausea and vomiting CINV underwent meta-analysis. The authors concluded that it may be suggested with caution that pharmaco-puncture may help various symptom relief in cancer patients; however, it is hard to draw a firm conclusion due to clinical heterogeneity and high ROB of the included studies, hence warranting further investigation.

Park et al noted that pharmaco-puncture is a new form of acupuncture combining acupuncture with herbal medicine, and it has been used under various conditions in Korea. These investigators examined clinical evidence for the safety and efficacy of pharmaco-puncture in Korea. They searched 9 databases and 2 relevant journals up to December using keywords, such as pharmaco-puncture. All RCTs evaluating pharmaco-puncture under any conditions in Korea were considered.

A total of 29 studies involving 1, participants were included. A meta-analysis of 2 studies on obesity showed that 5 to 8 weeks of pharmaco-puncture reduced weight, waist circumference, and BMI more than normal saline injections. The authors concluded that the findings of this systematic review suggested the potential of pharmaco-puncture for obesity and musculoskeletal diseases; however, it is difficult to recommend pharmaco-puncture as an evidence-based treatment because of methodological flaws and small sample sizes of the included studies.

These researchers stated that further well-designed trials are needed to draw a definitive conclusion. Cho et al stated that pharmaco-acupuncture is a new acupuncture treatment that stimulates acupuncture points by injecting herbal medicine into them. Recently, pharmaco-acupuncture has been widely used in the treatment of idiopathic Parkinson's disease PD in traditional East Asian medicine. In a systematic review, these investigators examined the safety and efficacy of pharmaco-acupuncture in the treatment of idiopathic PD.

The details of the pharmaco-acupuncture intervention, such as the herbal medicine and acupuncture points used, were also investigated. From studies, 3 RCTs were included; the number of patients analyzed was Most of the studies showed considerable methodological flaws.

There was heterogeneity of the intervention type and treatment duration in the included studies; thus, these researchers could not perform a meta-analysis. In 1 study, adjunctive bee venom pharmaco-acupuncture therapy significantly improved total UPDRS scores compared with conventional therapy alone. Another study, which used adjunctive Kakkonein pharmaco-acupuncture, did not reveal significant improvement compared with conventional therapy alone.

A 3rd study reported that Mailuoning pharmaco-acupuncture was able to significantly improve the modified Webster Symptom Score when compared with no treatment; AEs related to the pharmaco-acupuncture were reported in only 1 case, itching caused by the bee venom.

The authors concluded that the findings of this systematic review regarding the efficacy of pharmaco-acupuncture as a therapy for idiopathic PD are currently inconclusive. These researchers stated that further large and rigorous clinical trials are needed.

Although pharmaco-puncture with hominis placenta extract PLC is one of the new acupuncture therapies popular in East Asian medicine with a known efficacy in treating facial flushing, there has been little research on the safety and efficacy of this extract. Thus, this study aims to examine the safety and efficacy of pharmaco-puncture with hominis PLC compared to injections of normal saline, in peri- and post-menopausal women in Korea. This study is a randomized, placebo-controlled, single-blind, multi-center, parallel-design trial.

A total of peri- or post-menopausal women who meet the inclusion criteria will be recruited. The control group will receive injections of normal saline at the same acupoints during the same period. The authors concluded that they believe that this trial will provide evidence on the safety and efficacy of PLC pharmaco-puncture as a treatment for hot flashes in per- and post-menopausal women. Hwang et al stated musculoskeletal disorders are the main reason for individuals to seek counseling and use of CAM.

Although pharmaco-puncture is used to treat various diseases in traditional medicine, it is most often used in the treatment of musculoskeletal conditions. These investigators will review systematically the clinical evidence for the safety and effectiveness of pharmaco-puncture for musculoskeletal diseases. A total of 13 databases will be searched for studies up-loaded from January to December that examined the treatment of musculoskeletal diseases.

The methodological quality of RCTs will be analyzed using the Cochrane Collaboration tool to evaluate risk of bias, and the confidence in the cumulative evidence will be assessed using the GRADE instrument. This systematic review will be published in a peer-reviewed journal and disseminated electronically and in print.

Review History. Clinical Policy Bulletin Notes. Links to various non-Aetna sites are provided for your convenience only. Aetna Inc. Complementary and Alternative Medicine. Print Share. Number: Policy Aetna considers alternative medicine interventions medically necessary if they are supported by adequate evidence of safety and effectiveness in the peer-reviewed published medical literature.

Academy of Nutrition and Dietetics. Oncology evidence-based nutrition practice guideline. Obstet Gynecol. Clinical effects of colonic cleansing for general health promotion: A systematic review. Am J Gastroenterol. Airrosti Rehab Centers [website]. San Antonio, TX: Airrosti; Accessed July 11, Intravenous micronutrient therapy Myers' Cocktail for fibromyalgia: A placebo-controlled pilot study. J Altern Complement Med. Aliyev R. Clinical effects of the therapy method deep oscillation in treatment of sports injuries.

Sportverletz Sportschaden. American Art Therapy Association, Inc. Accessed June 8, Insulin potentiation therapy. Neural Therapy [website]. Making Treatment Decisions. Accessed April 21, American Dance Therapy Association [website]. Chelation Therapy. American Society of Group Psychotherapy and Psychodrama [website]. Accessed June8, Policy Statement. Accessed April 1, Conservative treatment of a female collegiate volleyball player with costochondritis.

Manipulative Physiol Ther. What is therapeutic eurythmy? The efficacy of 'distant healing': A systematic review of randomized trials. Ann Intern Med. Effects of acupressure on anxiety: A systematic review and meta-analysis. Acupunct Med. Usefulness of music therapy in clinical practice [summary]. A systematic review and meta-analysis of using acupuncture and acupressure for uremic pruritus.

Iran J Kidney Dis. Ball CM. Music therapy for children with autistic spectrum disorder. Bazian Ltd. Complementary and alternative medicine treatments for generalized anxiety disorder: Systematic review and meta-analysis of randomized controlled trials. Adv Ther. Allentown, PA: Chirobase; Accessed September 4, Dental Watch. Your Guide to Intelligent Dental Care [website]. Allentown, PA: Dental Watch; Barrett S, Korger M. Your Guide to Sensible Nutrition [website].

Allentown, PA: NutriWatch; Barrett S. Allentown, PA: HomeoWatch; MLM Watch. Your Skeptical Guide to Multilevel Marketing [website]. Allentown, PA: Quackwatch; Baumgaertel A. Pediatr Clin North Am. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. Bazzocchi G, Giuberti R.

Irrigation, lavage, colonic hydrotherapy: From beauty center to clinic? Tech Coloproctol. Bennett HJ. Using humor in the office setting: A pediatric perspective. J Fam Practice. Bielory L. Complementary and alternative therapies for allergic rhinitis and conjunctivitis. UpToDate [online serial]. Bioidentical hormone therapy: A review. Health Technol Assess. Bukstein O. Psychosocial interventions for substance use disorder in adolescents. UpToDate Inc.

Last reviewed February A pilot study comparing two manual therapy interventions for carpal tunnel syndrome. J Manipulative Physiol Ther. Late-onset infant group B streptococcus infection associated with maternal consumption of capsules containing dehydrated placenta — Oregon, On the choice of the extracellular vesicles for therapeutic purposes. Int J Mol Sci. Topical ozone therapy for the treatment of diabetic leg ulcers.

Pre-assessment No. Canadian Paediatric Society, Nutrition Committee. Megavitamin and megamineral therapy in childhood. Minutes of the Third Meeting - September 18, Accessed March 24, Canter PH, Ernst. Insufficient evidence to conclude whether or not transcendental meditation decreases blood pressure: Results of a systematic review of randomized clinical trials.

J Hypertension. Other complementary and alternative medicine modalities: Acupuncture, magnets, reflexology, and homeopathy. Am J Med. Management of cancer symptoms: Pain, depression, and fatigue. Cash BD, Schoenfeld P. Alternative medical therapies for dyspepsia: A systematic review of randomized trials.

In: Dyspepsia. Cassileth B, Chapman CC. Alternative and complementary cancer therapies. Music for pain relief. Static magnetic therapy does not decrease pain or opioid requirements: A randomized double-blind trial. Anesth Analg. Cersosimo RJ. Oxaliplatin-associated neuropathy: A review. Ann Pharmacother. Pharmacopuncture for cancer care: A systematic review. Evid Based Complement Alternat Med.

Pharmacoacupuncture for idiopathic Parkinson's disease: A systematic review of randomized controlled trials. To evaluate the efficacy and safety of PLC in perimenopausal for postmenopausal women with hot flashes: Study protocol for a randomized controlled trial. Static magnetic field therapy for carpal tunnel syndrome: A feasibility study.

Arch Phys Med Rehabil. Cooke B, Ernst E.